Rahul Sheth, MD
Vascular & Interventional Radiology · Houston, TXNPI 1932337979
Payments from drug & device makers
Across 494 payments — averaging $1034.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$135K
- Medtronic$82K
- Inari Medical, Inc.$82K
- Stryker$76K
- Janssen Research & Development, LLC$47K
- Siemens Medical Solutions USA, Inc.$30K
- plus $60K from 17 others
Across 4 payments — averaging $4253.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$17K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 144 | $135,018 |
| Medtronic(2 entities) | 102 | $81,907 |
| Inari Medical, Inc. | 54 | $81,522 |
| Stryker | 41 | $75,993 |
| Janssen Research & Development, LLC | 18 | $47,337 |
| Siemens Medical Solutions USA, Inc. | 45 | $29,561 |
| Trisalus Life Sciences, Inc. | 34 | $27,779 |
| Pfizer | 5 | $16,631 |
| Bard Peripheral Vascular, Inc. | 9 | $5,999 |
| Varian Medical Systems, Inc. | 5 | $3,675 |
| Guerbet LLC | 6 | $2,120 |
| Vertiflex, Inc. | 7 | $1,375 |
| BD | 1 | $827 |
| Icotec Medical Inc. | 9 | $468 |
| Endocare, Inc. | 3 | $232 |
| Penumbra, Inc. | 3 | $170 |
| Galvanize Therapeutics, Inc | 1 | $149 |
| Actelion Pharmaceuticals US, Inc. | 1 | $130 |
| Abbott | 2 | $36 |
| Novartis | 1 | $30 |
| Johnson & Johnson | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Medical Device Business Services, Inc. | 1 | $15 |
How this compares
$511,012 in reported general payments places this provider in the 95th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Houston
- Armeen MahvashHouston$2.6M
- Rony AvritscherHouston$1.3M
- Orlando DiazHouston$699K
- Miguel MonteroHouston$482K
- Marshall HicksHouston$403K
- Ahmed Abdel AalHouston$372K
- Joshua KubanHouston$349K
- Peiman HabibollahiHouston$254K
- Varshana GurusamyHouston$141K
- Ketan ShahHouston$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.